Comparative effectiveness in pain and haq-di improvement for baricitinib versus adalimumab, tocilizumab, and tofacitinib monotherapies in csdmard-naÏve rheumatoid arthritis patients: a matching-adjusted indirect comparison (MAIC)
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
BMJ Publishing Group
2018
|
| _version_ | 1797076312596152320 |
|---|---|
| author | Fautrel, B Zhu, B Taylor, P van de Laar, M Emery, P De Leonardis, F Gaich, C Nicolay, C Kadziola, Z De La Torre, I Fleischmann, R |
| author_facet | Fautrel, B Zhu, B Taylor, P van de Laar, M Emery, P De Leonardis, F Gaich, C Nicolay, C Kadziola, Z De La Torre, I Fleischmann, R |
| author_sort | Fautrel, B |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T00:02:18Z |
| format | Conference item |
| id | oxford-uuid:765edf14-c4b4-4459-a576-8ac2c51ab184 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T00:02:18Z |
| publishDate | 2018 |
| publisher | BMJ Publishing Group |
| record_format | dspace |
| spelling | oxford-uuid:765edf14-c4b4-4459-a576-8ac2c51ab1842022-03-26T20:15:25ZComparative effectiveness in pain and haq-di improvement for baricitinib versus adalimumab, tocilizumab, and tofacitinib monotherapies in csdmard-naÏve rheumatoid arthritis patients: a matching-adjusted indirect comparison (MAIC) Conference itemhttp://purl.org/coar/resource_type/c_5794uuid:765edf14-c4b4-4459-a576-8ac2c51ab184Symplectic Elements at OxfordBMJ Publishing Group2018Fautrel, BZhu, BTaylor, Pvan de Laar, MEmery, PDe Leonardis, FGaich, CNicolay, CKadziola, ZDe La Torre, IFleischmann, R |
| spellingShingle | Fautrel, B Zhu, B Taylor, P van de Laar, M Emery, P De Leonardis, F Gaich, C Nicolay, C Kadziola, Z De La Torre, I Fleischmann, R Comparative effectiveness in pain and haq-di improvement for baricitinib versus adalimumab, tocilizumab, and tofacitinib monotherapies in csdmard-naÏve rheumatoid arthritis patients: a matching-adjusted indirect comparison (MAIC) |
| title | Comparative effectiveness in pain and haq-di improvement for baricitinib versus adalimumab, tocilizumab, and tofacitinib monotherapies in csdmard-naÏve rheumatoid arthritis patients: a matching-adjusted indirect comparison (MAIC) |
| title_full | Comparative effectiveness in pain and haq-di improvement for baricitinib versus adalimumab, tocilizumab, and tofacitinib monotherapies in csdmard-naÏve rheumatoid arthritis patients: a matching-adjusted indirect comparison (MAIC) |
| title_fullStr | Comparative effectiveness in pain and haq-di improvement for baricitinib versus adalimumab, tocilizumab, and tofacitinib monotherapies in csdmard-naÏve rheumatoid arthritis patients: a matching-adjusted indirect comparison (MAIC) |
| title_full_unstemmed | Comparative effectiveness in pain and haq-di improvement for baricitinib versus adalimumab, tocilizumab, and tofacitinib monotherapies in csdmard-naÏve rheumatoid arthritis patients: a matching-adjusted indirect comparison (MAIC) |
| title_short | Comparative effectiveness in pain and haq-di improvement for baricitinib versus adalimumab, tocilizumab, and tofacitinib monotherapies in csdmard-naÏve rheumatoid arthritis patients: a matching-adjusted indirect comparison (MAIC) |
| title_sort | comparative effectiveness in pain and haq di improvement for baricitinib versus adalimumab tocilizumab and tofacitinib monotherapies in csdmard naive rheumatoid arthritis patients a matching adjusted indirect comparison maic |
| work_keys_str_mv | AT fautrelb comparativeeffectivenessinpainandhaqdiimprovementforbaricitinibversusadalimumabtocilizumabandtofacitinibmonotherapiesincsdmardnaiverheumatoidarthritispatientsamatchingadjustedindirectcomparisonmaic AT zhub comparativeeffectivenessinpainandhaqdiimprovementforbaricitinibversusadalimumabtocilizumabandtofacitinibmonotherapiesincsdmardnaiverheumatoidarthritispatientsamatchingadjustedindirectcomparisonmaic AT taylorp comparativeeffectivenessinpainandhaqdiimprovementforbaricitinibversusadalimumabtocilizumabandtofacitinibmonotherapiesincsdmardnaiverheumatoidarthritispatientsamatchingadjustedindirectcomparisonmaic AT vandelaarm comparativeeffectivenessinpainandhaqdiimprovementforbaricitinibversusadalimumabtocilizumabandtofacitinibmonotherapiesincsdmardnaiverheumatoidarthritispatientsamatchingadjustedindirectcomparisonmaic AT emeryp comparativeeffectivenessinpainandhaqdiimprovementforbaricitinibversusadalimumabtocilizumabandtofacitinibmonotherapiesincsdmardnaiverheumatoidarthritispatientsamatchingadjustedindirectcomparisonmaic AT deleonardisf comparativeeffectivenessinpainandhaqdiimprovementforbaricitinibversusadalimumabtocilizumabandtofacitinibmonotherapiesincsdmardnaiverheumatoidarthritispatientsamatchingadjustedindirectcomparisonmaic AT gaichc comparativeeffectivenessinpainandhaqdiimprovementforbaricitinibversusadalimumabtocilizumabandtofacitinibmonotherapiesincsdmardnaiverheumatoidarthritispatientsamatchingadjustedindirectcomparisonmaic AT nicolayc comparativeeffectivenessinpainandhaqdiimprovementforbaricitinibversusadalimumabtocilizumabandtofacitinibmonotherapiesincsdmardnaiverheumatoidarthritispatientsamatchingadjustedindirectcomparisonmaic AT kadziolaz comparativeeffectivenessinpainandhaqdiimprovementforbaricitinibversusadalimumabtocilizumabandtofacitinibmonotherapiesincsdmardnaiverheumatoidarthritispatientsamatchingadjustedindirectcomparisonmaic AT delatorrei comparativeeffectivenessinpainandhaqdiimprovementforbaricitinibversusadalimumabtocilizumabandtofacitinibmonotherapiesincsdmardnaiverheumatoidarthritispatientsamatchingadjustedindirectcomparisonmaic AT fleischmannr comparativeeffectivenessinpainandhaqdiimprovementforbaricitinibversusadalimumabtocilizumabandtofacitinibmonotherapiesincsdmardnaiverheumatoidarthritispatientsamatchingadjustedindirectcomparisonmaic |